Surfactant alterations in horses with recurrent airway obstruction at various clinical stages.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  American Journal of Veterinary Research

• Publication date

  2010-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2460/ajvr.71.4.468PMID 20367056
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relationship between clinical signs and lung function in horses with recurrent airway obstruction (heaves) during a bronchodilator trial.

  2010cited by this paper
• Current perspectives in pulmonary surfactant--inhibition, enhancement and evaluation.

  2008influential reference
• Surfactant in airway disease.

  2008cited by this paper
• Abnormalities in lung surfactant in horses clinically affected with recurrent airway obstruction (RAO).

  2008cited by this paper
• Lung function and airway cytologic profiles in horses with recurrent airway obstruction maintained in low-dust environments.

  2007cited by this paper
• 4 – Gas Exchange in Horses

  2007cited by this paper
• Time-dependent changes in pulmonary surfactant function and composition in acute respiratory distress syndrome due to pneumonia or aspiration

  2007cited by this paper
• Quantitative analysis of phospholipids by thin-layer chromatography and phosphorus analysis of spots

  2007cited by this paper
• European consensus guidelines on the management of neonatal respiratory distress syndrome

  2007cited by this paper
• Surfactant as an airway smooth muscle relaxant.

  2006cited by this paper
• Airway secretions and mucociliary function

  2006cited by this paper
• Myeloperoxidase concentration in bronchoalveolar lavage fluid from healthy horses and those with recurrent airway obstruction.

  2006cited by this paper
• Lysophospholipid and fatty acid inhibition of pulmonary surfactant: non-enzymatic models of phospholipase A2 surfactant hydrolysis.

  2005cited by this paper
• Surfactant phospholipid changes after antigen challenge: a role for phosphatidylglycerol in dysfunction.

  2005influential reference
• Immunoregulatory functions of surfactant proteins

  2005cited by this paper
• Eosinophil cationic protein alters pulmonary surfactant structure and function in asthma.

  2004cited by this paper
• Remodeling and inflammation of bronchi in asthma and chronic obstructive pulmonary disease.

  2004cited by this paper
• Airway mucus in recurrent airway obstruction--short-term response to environmental challenge.

  2004cited by this paper
• Clearance of surfactant lipids by neutrophils and macrophages isolated from the acutely inflamed lung.

  2002cited by this paper
• Pulmonary surfactant: functions, abnormalities and therapeutic options

  2001cited by this paper
• Comparison of inulin with urea as dilutional markers of bronchoalveolar lavage in healthy and heaves-affected horses.

  2001cited by this paper
• Altered airway surfactant phospholipid composition and reduced lung function in asthma.

  2000cited by this paper
• Phospholipid molecular species of bronchoalveolar lavage fluid after local allergen challenge in asthma.

  2000cited by this paper
• Suppression of neural activity of bronchial irritant receptors by surface‐active phospholipid in comparison with topical drugs commonly prescribed for asthma

  2000cited by this paper
• Pulmonary surfactant in health and human lung diseases: state of the art.

  1999cited by this paper
• Dysfunction of pulmonary surfactant in asthmatics after segmental allergen challenge.

  1999cited by this paper
• Antigen-induced airway inflammation in atopic subjects generates dysfunction of pulmonary surfactant.

  1999cited by this paper
• Cytokine-induced airway epithelial ICAM-1 upregulation: quantification by high-resolution scanning and transmission electron microscopy.

  1999cited by this paper
• Report of ERS Task Force: guidelines for measurement of acellular components and standardization of BAL.

  1999cited by this paper
• Dysfunction of guinea‐pig pulmonary surfactant and type II pneumocytes after repetitive challenge with aerosolized ovalbumin

  1997cited by this paper
• Exogenous surfactant enhances mucociliary clearance in the anaesthetized dog.

  1994cited by this paper
• Evaluation of urea and albumen as endogenous markers of dilution of equine bronchoalveolar lavage fluid.

  1993cited by this paper
• Effect of artificial surfactant on ciliary beat frequency in guinea pig trachea.

  1991cited by this paper
• Ultrastructural findings in horses with chronic obstructive pulmonary disease (COPD). I: Alterations of the larger conducting airways.

  1990cited by this paper
• Ultrastructural findings in horses with chronic obstructive pulmonary disease (COPD). II: Pathomorphological changes of the terminal airways and the alveolar region.

  1990influential reference
• Pulsating bubble technique for evaluating pulmonary surfactant.

  1977cited by this paper
• A rapid method of total lipid extraction and purification.

  1959cited by this paper
• Quantitative analysis

  year unknowncited by this paper

• Fatty acid fingerprints in bronchoalveolar lavage fluid and its extracellular vesicles reflect equine asthma severity

  2023cites this paper
• Lipidomic analysis of surfactant and plasma from horses with asthma and age-matched healthy horses.

  2022cites this paper
• Dynamics of DHA and EPA supplementation: incorporation into equine plasma, synovial fluid, and surfactant glycerophosphocholines

  2021cites this paper
• Diseases of the Respiratory System

  2020cites this paper
• Metabolomics analysis of bronchoalveolar lavage fluid samples in horses with naturally-occurring asthma and experimentally-induced airway inflammation.

  2020cites this paper
• Evaluation of lipid markers in surfactant obtained from asthmatic horses exposed to hay.

  2019cites this paper
• The Contribution of Oxidative Stress and Inflamm-Aging in Human and Equine Asthma

  2017cites this paper
• A review of the equine age-related changes in the immune system: comparisons between human and equine aging, with focus on lung-specific immune-aging.

  2015cites this paper
• INVITED REVIEW SERIES: CUTTING EDGE TECHNOLOGIES

  2011cites this paper